Active name: Vanzacaftor calcium dihydrate Brand name: ALYFTREK Innovator name VERTEX PHARMACEUTICALS INC Approval Date: Dec 20, 2024 Therapeutic activity: Binds to the different sites on the CFTR protein and have an additive effect in facilitating the cellular processing and trafficking of select mutant forms of CFTR (F508del-CFTR) to increase the amount of CFTR […]
API Flash News
Tag: Cystic fibrosis
Back To Top